Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
New Horizon Health HK$2.04 billion IPO
We advised New Horizon Health on its IPO and HKEX listing
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares
UP Fintech $65 million convertible notes private placement
We are advising UP Fintech, a Nasdaq-listed online brokerage firm, on its private placement of convertible notes
Youdao $238 million equity follow-on offering
We advised Youdao on its offering of ADSs
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
China SCE $350 million high-yield notes offering
We advised the initial purchasers on the Regulation S senior notes offering
Hopson Development $100 million high-yield notes reopening
We advised the initial purchasers on the Regulation S senior notes offering
Ocumension Therapeutics HK$793.8 million top-up placement of shares
We advised the placing agent in connection with the equity offering
Ronshine China Holdings $200 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
Venus Medtech HK$1.4 billion placing of new H shares
We advised Venus Medtech (Hangzhou) on its placement of new shares